articleTop 10% cited
Importance of Comorbidity in Head and Neck Cancer
The Laryngoscope · 2000 · Vol. 110(4) · pp. 593–602
Jay F. Piccirillo✉(Washington University in St. Louis)
Abstract
The results of this study show that comorbidity is an important feature of patients with head and neck cancer. Valid instruments exist to measure and classify the overall severity of comorbidity. The scientific evaluation of treatment and the care of patients are impeded by a rigid adherence to a staging system based solely on morphological descriptions of the cancer while ignoring suitable descriptions of the patient. The author believes that the addition of comorbidity information will improve the value of cancer statistics and the care of cancer patients.
Head and Neck Cancer StudiesOral Health Pathology and TreatmentComorbidityMedicineHead and neck cancerCancerCancer registryInternal medicineIncidence (geometry)Breast cancerIntensive care medicine
MeSH terms
AdultAgedAged, 80 and overBreast NeoplasmsFemaleGenital Neoplasms, FemaleHead and Neck NeoplasmsHealth Status IndicatorsHumansLung NeoplasmsMaleMiddle AgedNeoplasm StagingNeoplasms, Multiple PrimaryPrognosis
Citations
400
FWCI
8.85
field-weighted impact
References
19
Percentile
98%
vs. same field & year
Citations per year
Cited by
How to measure comorbiditya critical review of available methods
Journal of Clinical Epidemiology · 2003 · 1,751 citations
The development of a comorbidity index with physical function as the outcome
Journal of Clinical Epidemiology · 2005 · 1,194 citations
References
AJCC Cancer Staging Manual
JAMA · 2010 · 6,054 citations
Cancer statistics, 1994
CA A Cancer Journal for Clinicians · 1994 · 1,325 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
